THE CLINICAL EFFICACY OF THE PHYTOMEDICINE IN THE TREATMENT OF ACUTE RHINOSINUSITIS IN CHILDREN
https://doi.org/10.15690/pf.v9i2.239
Abstract
Acute rhinosinusitis is one of the most common diseases in childhood. Difficulties in identifying pathogens increase the importance of pathogenetic therapy. A study of clinical efficacy of mucolytic agents of herbal origin in the treatment of acute rhinosinusitis of 2 days period combined with respiratory viral infection in 95 children aged 4 to 14 years was carried out. The dynamics of the disease symptoms (rhinorrhea, nasal congestion, and olfaction) was estimated based on the diaries filled by parents every day. The study demonstrated the feasibility of the phytopreparation inclusion in the complex therapy of acute rhinosinusitis in children.
About the Authors
A. G. Volkov
Rostov State Medical University
Russian Federation
Russian Federation
N. V. Boyko
Rostov State Medical University
Russian Federation
Russian Federation
References
1. Tatochenko V.K. Vaccine / ed. V.K. Tatochenko, N. Ozeretskovsky, A. Fedorov. Moscow, 2009. 219p.
2. Kozlov R.S. Pneumococci: past, present and future. 2005. p. 20-21, 26-28.
3. Fedoseenko M.V. The prospect of pneumococcal vaccination: a modern approach to the problem. Breast cancer. 2009, 17 (1): 36-42.
4. Kostinov M.P. Vaccinational prevention of pneumococcal infection and influenza in autoimmune diseases. Guidelines for doctors. Moscow, 2009. p.183-207.
5. Djuretic T., Ryan M.J., Miller E. et al. Hospital admissions in children due to pneumococcal pneumonia in England. J. Infect. 1998; 37: 54–58.
6. Baraff L.J., Lee S.I., Schriger D.L. Outcomes of bacterial meningitis in children a meta-analysis. Pediatr Infect Dis J. 1993; 12: 389-394.
7. Mayansky N.A., Grechukha T.A., Zubkov I.V. et al. The level of antipneumococc antibodies and its dynamics after immunization with pneumococcal polysaccharide vaccine in children having nephrotic syndrome. Diagnostic issues in pediatrics. 2011, 3 (3): 42-46.
8. Bogaert D., De Groot R., Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004; 4: 144–154.
9. Mayansky A.N. Streptococci: microbiology and pathology. Diagnostic issues in pediatrics. 2010, 2 (2): 9-19.
10. Baranov A.A., Namazov L.S., V.K. Tatochenko. Pneumococcal disease and related disorders is a serious problem of modern health care. Pediatric pharmacology. 2008, 5 (2): 7-12.
11. Mayansky N.A., Alyabiev N.M., L.K. Katosova et al. The definition of capsular serotypes by using multiplex PCR vaccine. Diagnostic issues in pediatrics. 2010; 2 (6): 6-10.
12. Lopukhov L.V., M.V. Edelstein. Polymerase chain reaction in clinical microbiological diagnostics. Clinical Microbiology and Antimicrobial Chemotherapy. 2000, 2 (3): 96-106.
13. Roux A., Schmidt N., Rose M. et al. Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroids. Respir Med. 2004; 98: 1187–1194.
14. Harith S. Preventive vaccination: problems and prospects. Journal Infectology. 2009, 1 (1): 61-65
15. Garin E.H., Barrett D.J. Pneumococcal polysaccharide immunization in patients with active nephrotic syndrome. Nephron. 1988; 50: 383–388.
16. Tejani A., Fikrig S., Schiffman G., Gurumurthy K. Persistence of protective pneumococcal antibody following vaccination in patients with the nephrotic syndrome. Am J Nephrol. 1984; 4: 32–37.
17. Robinson K.A., Baughman W., Rothrock G. et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998: opportunities for prevention in the conjugate vaccine era. Jama. 2001; 285: 1729–1735.
18. Revathi R. Ramani, William N. Hall. Impact of PSV7 on invasive pneumococcal disease among children younger than 5 years: A population-based study. American Journal of Public Health. 2004; 94 (6): 958-959.
19. Black S., Shinefield H. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J. 2004; 23 (6): 485-489.
20. Gayvoronskaya A.G., V.V. Botvineva. Follow-up surveillance of children vaccinated against Haemophilus influenzae type b. Pediatric pharmacology. 2010, 7 (3): 18-21.
21. Kostinov M.P., Pakhomov D.V., Korovkina T.I., Andreeva N.P. Pharmacoeconomic impact of vaccination against pneumococcal and Haemophilus influenzae type B infection. Vaccination. News vaccination. 2009, 2 (58): 7-9.
Review
For citations:
Volkov A.G., Boyko N.V. THE CLINICAL EFFICACY OF THE PHYTOMEDICINE IN THE TREATMENT OF ACUTE RHINOSINUSITIS IN CHILDREN. Pediatric pharmacology. 2012;9(2):15-19. https://doi.org/10.15690/pf.v9i2.239
Views:
761
Email this article 